Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,759 | -645 | -1,145 | -368 | -173 |
| Depreciation Amortization | 1 | 1 | 0 | N/A | N/A |
| Accounts receivable | -115 | -37 | N/A | -21 | 3 |
| Accounts payable and accrued liabilities | 584 | 62 | N/A | 23 | -19 |
| Other Working Capital | 472 | 28 | 26 | -2 | -16 |
| Other Operating Activity | -455 | -16 | 254 | 67 | 76 |
| Operating Cash Flow | $-1,272 | $-607 | $-865 | $-301 | $-129 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -2 | -2 | -2 | N/A |
| Investing Cash Flow | $-29 | $-2 | $-2 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,371 | 5,371 | N/A | 992 | N/A |
| Other Financing Activity | -97 | -77 | 991 | 0 | 0 |
| Financing Cash Flow | $5,274 | $5,294 | $991 | $992 | $N/A |
| Beginning Cash Position | 270 | 270 | 146 | 146 | 146 |
| End Cash Position | 4,243 | 4,955 | 270 | 835 | 17 |
| Net Cash Flow | $3,973 | $4,685 | $124 | $689 | $-129 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,272 | -607 | -865 | -301 | -129 |
| Capital Expenditure | -29 | -2 | N/A | -2 | N/A |
| Free Cash Flow | -1,301 | -609 | -865 | -303 | -129 |